PRESS RELEASE
22 August 2025

SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals

M
Mintz

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC.
United States

Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.

“Mr. Yedid has taken full responsibility for his conduct and is looking forward to having this matter behind him,” Jason commented.

Source

Bloomberg Law

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More